Clinical Trial Update: Targeting Cerebellum to Treat Psychosis: a Transcranial Magnetic Stimulation (TMS) Study [NA]

View source ↗

Summary

A completed clinical trial evaluating transcranial magnetic stimulation targeting the cerebellum for schizophrenia-related psychosis with results posted in 2022…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder
• Schizoaffective Disorder
• Schizophrenia

Snippet

Sponsor: Mclean Hospital | Conditions: Schizophrenia, Schizoaffective Disorder | NA | Status: COMPLETED | Results posted: 2022-12-30